Table 3. Analysis of changes in serum lipid levels over time.
Lipids | n | month 12* | month 24 | mean change | 95% CI change | p-value |
Mean TC (mg/dL) | 209 | 159.5 | 163.9 | 4.4 | −0.6–9.4 | 0.083 |
% elevated TC (>200 mg/dL) | 12.1 | 21.1 | 0.1104 | |||
Mean LDL-c (mg/dL) | 131 | 86.4 | 88.1 | 1.7 | −2.5–6 | 0.42 |
% elevated LDL-c (>130 mg/dL) | 5.3 | 7.6 | 0.4955 | |||
Mean HDL-c (mg/dL) | 183 | 50.5 | 48.3 | −2.2 | −4.5–0.1 | 0.06 |
% decreased HDL-c (<40 mg/dL) | 27.3 | 31.6 | 0.908 | |||
Mean TG (mg/dL) | 202 | 96.5 | 103.3 | 6.6 | −1.4–14.8 | 0.106 |
% elevated TG (>110 mg/dL) | 29.5 | 37.6 | 0.005 | |||
Mean TC/HDL-c ratio | 183 | 3.3 | 3.6 | 0.3 | 0.2–0.4 | <0.001 |
% elevated TC/HDL-c ratio (>5) | 5.5 | 9.8 | 0.121 |
TC, total cholesterol; LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein cholesterol; TG, triglyceride.
At the time of enrolment into the study, after 12 months of stavudine containing ART.